secwatch.observer — SEC 8-K summary
======================================

Issuer:     BIOMERICA INC (BMRA)
CIK:        0000073290
Form:       8-K
Filed at:   2024-05-10T23:59:59+00:00
Accession:  0001493152-24-018697
Event type: regulatory
Sentiment:  negative
Materiality: 0.80
Item codes: 1.01, 3.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Biomerica receives Nasdaq bid price deficiency notice; enters $5.5M at-market stock offering
--------------------------------------------------------------------------------

- Nasdaq notified Biomerica on May 7, 2024 that bid price was below $1.00 for 32 consecutive business days, violating Listing Rule 5550(a)(2).
- Company has 180 days (until Nov 4, 2024) to regain compliance; 10 consecutive days at $1.00+ required.
- Entered At Market Issuance Sales Agreement with EF Hutton and R.F. Lafferty on May 10, 2024 to sell up to $5.5M of common stock.
- Proceeds for general corporate purposes including sales/marketing, clinical studies, product development, acquisitions, and working capital.
- Sales Agents receive 2.0% commission per share sold.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/73290/000149315224018697/0001493152-24-018697-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/73290/000149315224018697/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-24-018697

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer